Vimarsana
Biggest News Aggregation in the World

Page 3 - Clostridioides Difficile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clostridioides Difficile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clostridioides Difficile Today - Breaking & Trending Today

Common Hospital-Administered Antibiotics Linked to C Diff, Adverse Drug Reactions - Vimarsana News

Common Hospital-Administered Antibiotics Linked to C Diff, Adverse Drug Reactions

Ciprofloxacin, ceftriaxone, and piperacillin/tazobactam showed the greatest associations with adverse drug reaction case reports related to CDI.

Common hospital disinfectant doesn't work against C. diff, study finds - Vimarsana News

Common hospital disinfectant doesn't work against C. diff, study finds

Study finds that a CDC-recommended hospital disinfectant is ineffective against Clostridioides difficile, a hospital-acquired infection affecting 500,000 Americans every year.

Black Patients Receive Less C Diff Tests Despite Similar Positivity Rates to White Patients - Vimarsana News

Black Patients Receive Less C Diff Tests Despite Similar Positivity Rates to White Patients

A retrospective cohort study of inpatient encounters from 3 hospitals in the Duke University Health System showed greater rates of testing among White patients compared to Black and NWNB patients.

Organelles protect <em>Clostridioides difficile</em> from iron overdose - Vimarsana News

Organelles protect <em>Clostridioides difficile</em> from iron overdose

The bacterium Clostridioides difficile (C. difficile) forms organelles that help them defend against iron in the colon. According to a group of scientists from Vanderbilt University, this pathogen, which causes serious gastrointestinal infections, expresses fez genes to build structures called ferrosomes that store excess iron that is toxic to it. Its ferrosomes are surrounded by membrane and could be a target against this microorganism.

2nd choice drug reduced C. diff infections by 45% - Vimarsana News

2nd choice drug reduced C. diff infections by 45%

Study finds that doxycycline, an antibiotic typically reserved as an alternative to azithromycin, is associated with reducing clostridioides difficile infections in pneumonia patients.